[en] BACKGROUND: Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice. The goal of the present analysis was to describe HR in such patients, overall and in relation to beta-blocker use, and to describe the determinants of HR. METHODS AND FINDINGS: CLARIFY is an international, prospective, observational, longitudinal registry of outpatients with stable CAD, defined as prior myocardial infarction or revascularization procedure, evidence of coronary stenosis of >50%, or chest pain associated with proven myocardial ischemia. A total of 33,438 patients from 45 countries in Europe, the Americas, Africa, Middle East, and Asia/Pacific were enrolled between November 2009 and July 2010. Most of the 33,177 patients included in this analysis were men (77.5%). Mean (SD) age was 64.2 (10.5) years, HR by pulse was 68.3 (10.6) bpm, and by electrocardiogram was 67.2 (11.4) bpm. Overall, 44.0% had HR >/= 70 bpm. Beta-blockers were used in 75.1% of patients and another 14.4% had intolerance or contraindications to beta-blocker therapy. Among 24,910 patients on beta-blockers, 41.1% had HR >/= 70 bpm. HR >/= 70 bpm was independently associated with higher prevalence and severity of angina, more frequent evidence of myocardial ischemia, and lack of use of HR-lowering agents. CONCLUSIONS: Despite a high rate of use of beta-blockers, stable CAD patients often have resting HR >/= 70 bpm, which was associated with an overall worse health status, more frequent angina and ischemia. Further HR lowering is possible in many patients with CAD. Whether it will improve symptoms and outcomes is being tested.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Murray CJ, Lopez AD, (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276.
Anderson GF, Chu E, (2007) Expanding priorities-confronting chronic disease in countries with low income. N Engl J Med 356: 209-211.
Steg PG, (2009) Heart rate management in coronary artery disease: the CLARIFY registry. Eur Heart J 11 (suppl D): D13-D18.
Diaz A, Bourassa MG, Guertin MC, Tardif JC, (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26: 967-974.
Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, et al. (1990) Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 65: 547-553.
Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, et al. (2008) Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 29: 1327-1334.
Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, et al. (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50: 823-830.
Fox K, Ford I, Steg PG, Tendera M, Robertson M, et al. (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372: 817-821.
Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, et al. (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376: 886-894.
Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, et al. (2009) Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ 338: b219.
Freemantle N, Cleland J, Young P, Mason J, Harrison J, (1999) beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318: 1730-1737.
Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators (2009) Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 30: 540-548.
Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators Group (2003) Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107: 817-823.
Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, et al. (2005) Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26: 2529-2536.
Fox K, Ford I, Steg PG, Tendera M, Ferrari R, et al. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372: 807-816.
Fox K, Ford I, Steg PG, Tendera M, Robertson M, et al. (2009) Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J 30: 2337-2345.
Fox K, Ford I, Steg PG, Tendera M, Ferrari R, (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372: 807-816.
Antoni ML, Boden H, Delgado V, Boersma E, Fox K, et al. (2012) Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J 33: 96-102.
Rambihar S, Gao P, Teo K, Bohm M, Yusuf S, et al. (2010) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Circulation 122: A12667.
Waters DD, Ho J, Demicco DA, Breazna A, Pedersen TR, (2010) Heart rate as a predictor of cardiovascular risk in coronary heart disease patients with diabetes. Eur Heart J 31 (Abstract Suppl): 801.
Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, et al. (2010) Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol 105: 905-911.
Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, et al. (1999) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 33: 2092-2197.
Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, et al. (2010) Inadequate control of heart rate in patients with stable angina: results from the European heart survey. Postgrad Med J 86: 212-217.
Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, et al. (2006) Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27: 1341-1381.
Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, et al. (2007) 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 50: 2264-2274.
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
Bagnall AJ, Yan AT, Yan RT, Lee CH, Tan M, et al. (2010) Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge. Circulation Cardiovascular quality and outcomes 3: 530-537.
Heidenreich PA, McDonald KM, Hastie T, Fadel B, Hagan V, et al. (1999) Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 281: 1927-1936.
Steg PG, Lopez-Sendon J, Lopez de Sa E, Goodman SG, Gore JM, et al. (2007) External validity of clinical trials in acute myocardial infarction. Arch Intern Med 167: 68-73.
Rothwell PM, (2005) External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 365: 82-93.
Clausen JP, (1976) Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease. Prog Cardiovasc Dis 18: 459-495.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.